Platelet-activating factor plays a pivotal role in the induction of experimental lung injury

American Journal of Respiratory Cell and Molecular Biology

Volumn 18, Issue 2, 1998, Pages 197-204

  Miotla, Jadwiga M ^a,b   Jeffery, Peter K ^a   Hellewell, Paul G ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; COBROTOXIN; DIHYDROPYRIDINE DERIVATIVE; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; IMIDAZOLE DERIVATIVE; LIPOPOLYSACCHARIDE; MODIPAFANT; PEROXIDASE; SERUM ALBUMIN; SNAKE VENOM; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; ZYMOSAN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CAPILLARY PERMEABILITY; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOLOGY; LUNG; LUNG EXTRAVASCULAR FLUID; METABOLISM; MOUSE; NEUTROPHIL; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN;

ANIMALS; CAPILLARY PERMEABILITY; COBRA VENOMS; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; EXTRAVASCULAR LUNG WATER; FEMALE; HUMANS; IMIDAZOLES; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED BALB C; NEUTROPHILS; PEROXIDASE; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RESPIRATORY DISTRESS SYNDROME, ADULT; SERUM ALBUMIN; SKIN; ZYMOSAN;

EID: 0031992726     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.18.2.2846     Document Type: Article

References (51)

1. Anderson, R., R. Holliday, A. Driedger, M. Lefcoe, B. Reid, and W. Sibbald. 1979. Documentation of pulmonary capillary permeability in the ARDS accompanying human sepsis. Am. Rev. Respir. Dis. 119:869-877.
2. Tate, R. M., and J. E. Repine. 1983. Neutrophils and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 128:S52-S59.
3. Lopez Diez, F., M. Nieto, S. Fernandez-Gallordo, M. Gijon, and M. Sanchez-Crespo. 1989. Occupancy of platelet receptors for platelet-activating factor in patients with septicemia. J. Clin. Invest. 83:1733-1740.
4. 2 in patients with septic shock and trauma. Intensive Care Med. 20:555-561.
5. Chang, S. 1994. Endotoxin-induced pulmonary leukostasis in the rat: the role of platelet-activating factor and tumour necrosis factor. J. Lab. Clin. Med. 123:65-72.
6. Worthen, G. S., C. Haslelt, A. J. Rees, R. S. Gumbay, J. E. Henson, and P. M. Henson. 1987. Neutrophil-medialed pulmonary vascular injury: synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. Am. Rev. Respir. Dis. 136:19-28.
7. Welsh, C., D. Lien, G. Worthen, P. Henson, and J. Weil. 1989. Endotoxin-pretreated neutrophils increase pulmonary vascular permeability in dogs. J. Appl. Physiol. 66:112-119.
8. Cardozo, C., J. Edelman, J. Jagirdar, and M. Lesser. 1991. Lipopolysaccharide-induced pulmonary vascular sequestration of polymorphonuclear leukocytes is complement independent. Am. Rev. Respir. Dis. 144:173-178.
9. Kanazawa, M., A. Ishizaka, N. Hasegawa, Y. Suzuki, and T. Yokoyama. 1992. Granulocyte colony stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pies. Am. Rev. Respir. Dis. 145:1030-1035.
10. Chang, S., C. Feddersen, P. Henson, and N. Voelkel. 1987. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J. Clin. Invest. 79:1498-1509.
11. Inarrea, P., J. Gomez-Cambronero, J. Pascual, M. del Carmen Ponte, L. Hernando, and M. Sanchez-Crespo. 1985. Synthesis of PAF-acether and blood volume changes in gram-negative sepsis. Immunopharmacology 9: 45-52.
12. Doebber, T., M. Wu, J. Robbins, B. Choy, M. Chang, and T. Shen. 1985. PAF involvement in endotoxin-induced hypotension in rats: studies with PAF receptor antagonist kadsurenone. Biochem. Biophys. Res. Commun. 127:799-808.
13. Matsumoto, K., F. Taki, Y. Kondoh, H. Taniguchi, and K. Takagi. 1992. Platelet-activating factor in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Clin. Exp. Pharmacol. Physiol. 19: 509-515.
14. Angle, M. J., R. N. Pinckaed, H. J. Showell, and L. M. McManus. 1987. Ontogeny of the responsiveness to intravenous platelet-activating factor. Lab. Invest. 57:321-328.
15. Burhop, K. E., J. G. N. Garcia, W. M. Selig, S. K. Lo, H. Van der Lee, J. E. Kaplan, and A. B. Malik. 1986. Platelet-activating factor increases lung vascular permeability to protein. J. Appl. Physiol. 61:2210-2217.
16. Christman, B. W., P. L. Lefferts, G. A. King, and J. R. Snapper. 1988. Role of circulating platelets and granulocytes in PAF-induced pulmonary dysfunction in awake sheep. J. Appl. Physiol. 64:2033-2041.
17. Hamasaki, Y., M. Morajad, T. Saga, H. Tai, and S. Said. 1984. Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution. Am. Rev. Respir. Dis. 129:742-746.
18. Kingsnorth, A. N., S. W. Galloway, and L. J. Formela. 1995. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br. J. Surg. 82:1414-1420.
19. Dhainaut, J., A. Tenaillon, Y. Le Tulzo, B. Schlemmer, J. Solet, M. Wolff, L. Holzappel, F. Zeni, D. Dreyfuss, J. Mira. F. de Vathaire, P. Guinot, and the BN52021 Sepsis Study Group. 1994. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomised, double-blind, placebo-controlled, multicenter clinical trial. Crit. Care Med. 22:1720-1728.
20. Miotla, J. M., T. J. Williams, P. G. Hellewell, and P. K. Jeffery. 1986. A role for the β2 integrin CD11b in mediating experimental lung injury in mice. Am. J. Respir. Cell Mol. Biol. 14:363-373.
21. Tvedten, H., G. Till, and P. Ward. 1985. Mediators of lung injury in mice following systemic activation of complement. Am. J. Pathol. 119:92-100.
22. Sanchez-Crespo, M., F. Alonso, and J. Egido. 1980. Platelet-activating factor in anaphylaxis and phagocytosis. 1. Release from human peripheral polymorphonuclears and monocytes during the stimulation by ionophore A23187 and phagocytosis hut not from degranulating basophils. Immunology 40:645-655.
23. Betz, S. J., and P. M. Henson. 1980. Production and release of platelet-activating factor (PAF): dissociation from degranulation and superoxide production in the human neutrophil. J. Immunol. 125:2756-2763.
24. Parry, M. J., V. A. Alabaster, H. E. Cheeseman, K. Cooper, K. N. deSouza, and R. F. Keir. 1944. Pharmacological profile of UK-74,505, a novel and selective PAF antagonist with potent and prolonged oral activity. J. Lipid Mediators Cell Signalling 10:251-268.
25. Hunter, W. M. and E. C. Greenwood. 1962. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (London) 194:495-496.
26. 36Cl in sheep lung. J. Appl. Physiol. 39:773-779.
27. Pons, F., A. G. Rossi, K. E. Norman, T. J. Williams, and S. Nourshargh. 1993. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist. UK-74,505. Br. J. Pharmacol. 109:234-242.
28. Sanz, M.-J., V. B. Weg, M. A. Bolanowski, and S. Nourshargh. 1995. IL-1 is a potent inducer of eosinophil accumulation in rat skin: inhibition of responses by a platelet-activating factor antagonist and an anti-human IL-8 antibody. J. Immunol. 154:1364-1373.
29. Williams, F. M., M. Kus, K. Tanda, and T. J. Williams. 1994. Effect of duration of ischaemia on reduction of myocardial infarct size by inhibition of neutrophil accumulation using an anti-CD18 monoclonal antibody. Br. J. Pharmacol. 111:1123-1128.
30. Warren, J. S., K. R. Yabroff, D. G. Remick, S. L. Kunkel, S. W. Chesnue, R. G. Kunkel, K. J. Johnson, and P. A. Ward. 1989. Tumor necrosis factor participates in the palhogenesis of acute immune complex alveolitis in the rat. J. Clin. Invest. 84:1873-1880.
31. Babior, B. M., R. S. Kipnes, and J. T. Curnutte. 1973. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 52:741-744.
32. Perkowski, S., A. Havill, J. Flynn, and M. Gee. 1983. Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation. Circ. Res. 53:574-583.
33. Till, G. O., K. J. Johnson, R. Kunkel, and P. A. Ward. 1982. Intravascular activation of complement and acute lung injury: dependency on neutrophils and toxic oxygen metabolites. J. Clin. Invest. 69:1126-1135.
34. Suzuki, Y., T. Tanigaki, D. Heimer, W. Wang, W. Ross, H. Sussman, and T. Raffin. 1992. Polyethylene glycol-conjugated superoxide dismutase attenuates septic lung injury in guinea pigs. Am. Rev. Respir. Dis. 145:388-393.
35. Worthen, G. S., J. F. Seccombe, K. L. Clay, L. A. Guthrie, and R. B. Johnston. 1988. The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. J. Immunol. 140:3553-3559.
36. Lynch, J. M., and P. M. Henson. 1986. The intracellular retention of newly synthesized platelet-activating factor. J. Immunol. 137:2653-2661.
37. 2+ in human neutrophils induced by opsonized particles. FEBS Lett. 259:209-212.
38. Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Invest. 79: 319-326.
39. Stern, D. M., I. Hank, P. P. Naworth, J. Cassimersis, W. Kisiel, J. W. Fenton H. C. Dinarello, L. Chess, and H. A. Jaffe. 1985. Self-regulation of procoagulant events on the endothelial cell surface. J. Exp. Med. 162:1223-1235.
40. Sullivan, G., H. Carper, J. Sullivan, I. Murata, and G. Mandell. 1989. Both recombinant interleukin-1 (beta) and purified human monocyte interleukin-1 prime human neutrophils for increased oxidative activity and promote neutrophil spreading. J. Leuk. Biol. 45:389-395.
41. Pabst, M. J. 1994. Priming of neutrophils. In Immunopharmacology of Neutrophils. P. G. Hellewell and T. J. Williams, editors. Academic Press. London. 195-221.
42. Kuipers, B., T. van der Poll, M. Levi, S. J. H. van Deventer, H. ten Cate, Y. Imai, C. E. Hack, and J. W. ten Cate. 1994. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees. J. Immunol. 152:2438-2446.
43. Zimmerman, G. A., T. M. McIntyre, M. Mehra, and S. M. Preseott, 1990. Endothelial cell-associated platelet-activating factor: a novel mechanism for signalling intercellular adhesion. J. Cell Biol. 110:529-540.
44. Lorant, D. E., K. D. Patel, T. M. McIntyre, R. P. McEver, S. M. Prescott, and G. A. Zimmerman. 1991. Coexpression of GMP-140 and PAF hy endothelium stimulated hy histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J. Cell Biol. 115:223-234.
45. Honda, Z., M. Nakamura, I. Miki, M. Minami, T. Watanabe, Y. Seyama, H. Okado, H. Toh, K. Ito, T. Miyamoto, and I. Shimizu. 1991. Cloning by functional expression of platelet-activating receptor from guinea pig lung. Nature (London) 349:342-346.
46. Miotla, J., T. Williams, P. Jeffery, and P. Hellewell. 1994. A role for ICAM-1 in mediating neutrophil-induced increased pulmonary vascular permeability in the mouse. Am. Rev. Respir. Dis. 149:A1092. (Abstr.)
47. Kuijpers, T. W., B. C. Hakkert, M. H. L. Hart, and D. Roos. 1992. Neutiophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. J. Cell Biol. 117:565-572.
48. Hill, M., I. Bird, R. Daniels, M. Elmore, and M. Linnen. 1994. Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1β-treated endothelial monolayers. J. Immunol. 153:3673-3683.
49. Mayadas, T. N., R. C. Johnson, H. Rayburn, R. O. Hynes, and D. D. Wagner. 1993. Leukocyte rolling and extravasation are severely compromised in P-selectin deficient mice. Cell 74:541-554.
50. Coughlan, A. F., H. Hau, L. C. Dunlop, M. C. Berndt, and W. W. Hancock, 1994. P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia. J. Exp. Med. 179:329-334.
51. Erzurum, S. C., G. P. Downey, D. E. Doherty, B. Schwab, E. L. Elson, and G. S. Worthen. 1992. Mechanisms of lipopolysaccharide-induced neutrophil retention: relative contributions of adhesive and cellular mechanical properties. J. Immunol. 149:154-162.